Brainstorm Cell Therapeutics's total assets for Q2 2024 were $5.68M, an increase of 69.74% from the previous quarter. BCLI total liabilities were $9.21M for the fiscal quarter, a 3.51% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.